[Thyrotropic hormone receptor antibodies in the diagnosis and treatment of Graves-Basedow disease].
In 1956, D. Adams and N. Purves first discovered a factor in the serum of patients with Graves-Bazedov's disease (toxic goiter) that stimulated the thyroid gland, but differed in structure from thyroid-stimulating hormone (TSH). In the early 80s, several researchers discovered the existence of a special group of antibodies to rTSH- TGAb (thyroid growth antibodies - antibodies that stimulate thyroid growth).